Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × Serotonin Syndrome × Clear all

Phase

Status

Sponsor Class

OTHER 10 INDUSTRY 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 180 Carcinoma, Non-Small-Cell Lung 121 Lung Neoplasms 106 Lymphoma 98 Prostatic Neoplasms 91 Leukemia 83 Central Nervous System Neoplasms 83 Ovarian Neoplasms 82 Colorectal Neoplasms 78 Sarcoma 76 Precursor Cell Lymphoblastic Leukemia-Lymphoma 74 Multiple Myeloma 72 Head and Neck Neoplasms 72 Squamous Cell Carcinoma of Head and Neck 61 Rectal Neoplasms 59 Neoplasm Metastasis 55 Uterine Cervical Neoplasms 52 Brain Neoplasms 52 Carcinoma, Ovarian Epithelial 51 Colonic Neoplasms 50 Leukemia, Myeloid, Acute 49 Astrocytoma 48 Fallopian Tube Neoplasms 45 Urinary Bladder Neoplasms 44 Lymphoma, Large B-Cell, Diffuse 43 Glioblastoma 43 Neuroblastoma 39 Melanoma 39 Hodgkin Disease 39 Burkitt Lymphoma 38

Interventions

telotristat ethyl 1 lanreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065165 2020-02-05

TELEFIRST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡